home / stock / bfriw / bfriw quote
Last: | $0.038128 |
---|---|
Change Percent: | -31.79% |
Open: | $0.05025 |
Close: | $0.038128 |
High: | $0.05025 |
Low: | $0.035 |
Volume: | 5,880 |
Last Trade Date Time: | 06/27/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.038128 | $0.05025 | $0.038128 | $0.05025 | $0.035 | 5,880 | 06-27-2024 |
$0.0405 | $0.0405 | $0.0405 | $0.0405 | $0.0405 | 179 | 06-26-2024 |
$0.0405 | $0.0405 | $0.0405 | $0.0405 | $0.0405 | 380 | 06-25-2024 |
$0.045 | $0 | $0.045 | $0 | $0 | 320 | 06-24-2024 |
$0.045 | $0.045 | $0.045 | $0.045 | $0.045 | 126 | 06-20-2024 |
$0.045 | $0.0598 | $0.045 | $0.0598 | $0.045 | 700 | 06-13-2024 |
$0.05995 | $0.05995 | $0.05995 | $0.05995 | $0.05995 | 120 | 05-30-2024 |
$0.045 | $0.05 | $0.045 | $0.05 | $0.045 | 5,111 | 05-28-2024 |
$0.0525 | $0 | $0.0525 | $0 | $0 | 90 | 05-24-2024 |
$0.0525 | $0.0408 | $0.0525 | $0.0758 | $0.0408 | 10,960 | 05-23-2024 |
$0.0402 | $0.0659 | $0.0402 | $0.0659 | $0.0402 | 1,000 | 05-21-2024 |
$0.065 | $0 | $0.065 | $0 | $0 | 60 | 05-20-2024 |
$0.065 | $0.0649 | $0.065 | $0.0659 | $0.0649 | 18,941 | 05-15-2024 |
$0.065 | $0.04 | $0.065 | $0.065 | $0.04 | 600 | 05-13-2024 |
$0.064999 | $0 | $0.064999 | $0 | $0 | 4 | 05-10-2024 |
$0.064999 | $0.0595 | $0.064999 | $0.065 | $0.0595 | 26,955 | 05-09-2024 |
$0.06 | $0 | $0.06 | $0 | $0 | 2 | 05-07-2024 |
$0.06 | $0.0595 | $0.06 | $0.06 | $0.0595 | 17,010 | 05-03-2024 |
$0.06 | $0.059899 | $0.06 | $0.06 | $0.059899 | 5,000 | 04-29-2024 |
$0.06 | $0.06 | $0.06 | $0.06 | $0.06 | 400 | 04-26-2024 |
News, Short Squeeze, Breakout and More Instantly...
Biofrontera Inc. Warrants Company Name:
BFRIW Stock Symbol:
NASDAQ Market:
Biofrontera Inc. Warrants Website:
The RhodoLED XL is approved by the FDA in combination with Ameluz ® (aminolevulinic acid hydrochloride) topical gel, 10% for photodynamic therapy (PDT) of actinic keratoses of mild-to-moderate severity on the face and scalp Biofrontera launched the commercial distribution of the Rhod...
WOBURN, Mass., Nov. 30, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, announced today that the Company will be participating in Benchmark’s 11th Annual Discovery One-on-One I...
Woburn, Nov. 28, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. ("Biofrontera" or the "Company") (NASDAQ: BFRI), announced today that they will be participating in Renmark Financial Communications Inc.’s live Virtual Non-Deal Roadshow Series to discuss its latest investor presentation on ...